Provided are antibodies that bind and inhibit CD73, are capable of increasing the proliferation of T cells in the presence of CD39-expressing B cells and ATP. The invention also relates to cells producing such compounds； methods of making such compounds, and antibodies, fragments, variants, and derivatives thereof； pharmaceutical compositions comprising the same； methods of using the compounds to diagnose, treat or prevent cancer.
